Another study demonstrates that inhibiting HDAC9 in HCC decreases ALDH1A3 expression, and the sphere formation ability of HCC cells is significantly suppressed by the ALDH inhibitor disulfiram 38. Here, ALDH1A3 is linked to hepatocellular carcinoma.